Your browser doesn't support javascript.
loading
Editorial Expression of Concern: p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells.
Hideshima, Teru; Podar, Klaus; Chauhan, Dharminder; Ishitsuka, Kenji; Mitsiades, Constantine; Tai, Yu-Tzu; Hamasaki, Makoto; Raje, Noopur; Hideshima, Hiromasa; Schreiner, George; Nguyen, Aaron N; Navas, Tony; Munshi, Nikhil C; Richardson, Paul G; Higgins, Linda S; Anderson, Kenneth C.
Afiliação
  • Hideshima T; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Podar K; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Chauhan D; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Ishitsuka K; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Mitsiades C; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Tai YT; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Hamasaki M; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Raje N; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Hideshima H; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Schreiner G; Scios Inc., 6500 Paseo Padre Parkway, Fremont, CA, 94555, USA.
  • Nguyen AN; Scios Inc., 6500 Paseo Padre Parkway, Fremont, CA, 94555, USA.
  • Navas T; Scios Inc., 6500 Paseo Padre Parkway, Fremont, CA, 94555, USA.
  • Munshi NC; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Richardson PG; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA.
  • Higgins LS; Scios Inc., 6500 Paseo Padre Parkway, Fremont, CA, 94555, USA.
  • Anderson KC; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Mayer 557, 44 Binney Street, Boston, MA, 02115, USA. kenneth_anderson@dfci.harvard.edu.
Oncogene ; 43(40): 3018, 2024 Sep.
Article em En | MEDLINE | ID: mdl-39209967

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Quinases p38 Ativadas por Mitógeno / Bortezomib / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Quinases p38 Ativadas por Mitógeno / Bortezomib / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos